EPITOPE SUMMARY
(5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(8-phenyloctyl)octanamide (epitope ID ) has this structure: . The epitope has these synonyms: (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactopyranosyloxy)-7-(octanoylamino)-N-(6-phenyloctyl)octanamide, (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(8-phenyloctyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide, (5R,6S,7S)-5,6-dihydroxy-8-O-(alpha-D-galactopyranosyl)-7-octanamido-N-(8-phenyloctyl)octanamide, N-((2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-3,4-dihydroxy-16-phenylhexadecan-2-yl)octanamide. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, MHC ligand assay and has 3D structure(s) .
CURATED EXPERIMENTAL DATA
MHC Ligand Assay(s)
MHC moleculePositive / All
mouse CD1d
T Cell Assay(s)
Assay TypePositive / All
3D structure
dissociation constant KD
IL-2 release
off rate
on rate
EXTERNAL RESOURCES
ResourceLink